• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以骨骼肌为重点的指南制定:包含肌肉形态、功能和临床结果的层次模型。

Skeletal muscle-focused guideline development: hierarchical model incorporating muscle form, function, and clinical outcomes.

机构信息

Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA, USA.

Department of Agricultural, Food & Nutritional Science, Human Nutrition Research Unit, University of Alberta, Edmonton, AB, Canada.

出版信息

Appl Physiol Nutr Metab. 2023 Oct 1;48(10):751-756. doi: 10.1139/apnm-2023-0176. Epub 2023 Jul 20.

DOI:10.1139/apnm-2023-0176
PMID:37473448
Abstract

Sarcopenia, sarcopenic obesity, malnutrition, and cachexia clinical guidelines were created by expert consensus over the past decade. These pathological states all share in common deficits in skeletal muscle mass, and in some cases muscle function, which adversely impact patient outcomes. Early identification is key as some detrimental outcomes are potentially preventable with available treatments. The four guidelines share common design features: patients suspected of having the condition are first screened with a focused clinical history; if positive, the next step is evaluation with either a measure of body "form" (e.g., mass, shape, and composition) or function (e.g., mechanical, endurance, and metabolic); combined form and functional criteria are also recognized. The form and functional "gateway" nodes establish whether or not to proceed with further evaluations and treatments. Intensive discussions among experts focus on selection of these gateway nodes and the final choice is made when consensus is reached. Form and functional measures are often treated as equivalent alternatives when framed in the context of "outcomes" for which they are intended to predict. Here we adapt a classic biological concept stating that "function follows form" to show that pathophysiological links are present between these two different muscle qualities and clinical outcomes. We argue that a hierarchy exists such that outcomes closely follow functions that, in turn, follow form…the OFF rule. The OFF rule explains why functional measures often show stronger associations with outcomes than those quantifying form, helps to frame debates on how to structure the gateway nodes used to identify patients for further evaluation and treatment, and sets out a pathophysiological structure for developing future outcome prediction models.

摘要

肌肉减少症、肌少症合并肥胖症、营养不良和恶病质的临床指南是过去十年间通过专家共识制定的。这些病理状态都存在骨骼肌质量下降,某些情况下还伴有肌肉功能下降,这会对患者的预后产生不利影响。早期识别是关键,因为一些不良结局可能可以通过现有治疗来预防。这四条指南具有共同的设计特征:首先,对疑似患有该疾病的患者进行有针对性的临床病史筛查;如果阳性,下一步是使用身体“形态”(如质量、形状和组成)或功能(如机械、耐力和代谢)的测量方法进行评估;也认可形态和功能联合标准。形态和功能“门户”节点确定是否进行进一步评估和治疗。专家之间进行了深入讨论,重点是选择这些门户节点,最终选择是在达成共识时做出的。在为预期的“结果”构建框架时,形态和功能测量通常被视为等效的替代方法。在这里,我们改编了一个经典的生物学概念,即“功能决定形态”,以表明这两种不同的肌肉质量与临床结果之间存在病理生理联系。我们认为存在一种层次结构,结果密切跟随功能,功能又跟随形态……即“OFF 规则”。OFF 规则解释了为什么功能测量通常比定量形态的测量与结果具有更强的关联,有助于围绕如何构建用于识别患者以进行进一步评估和治疗的门户节点展开辩论,并为开发未来的结果预测模型提供了病理生理学结构。

相似文献

1
Skeletal muscle-focused guideline development: hierarchical model incorporating muscle form, function, and clinical outcomes.以骨骼肌为重点的指南制定:包含肌肉形态、功能和临床结果的层次模型。
Appl Physiol Nutr Metab. 2023 Oct 1;48(10):751-756. doi: 10.1139/apnm-2023-0176. Epub 2023 Jul 20.
2
Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.肌肉收缩和代谢功能障碍是衰老和慢性疾病导致的肌肉减少症的共同特征:从肌肉减少性肥胖到恶病质。
Clin Nutr. 2014 Oct;33(5):737-48. doi: 10.1016/j.clnu.2014.03.007. Epub 2014 Mar 29.
3
Validated screening tools for the assessment of cachexia, sarcopenia, and malnutrition: a systematic review.用于评估恶病质、肌肉减少症和营养不良的经过验证的筛选工具:系统评价。
Am J Clin Nutr. 2018 Dec 1;108(6):1196-1208. doi: 10.1093/ajcn/nqy244.
4
Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement.定义和诊断肌少症性肥胖的标准:ESPEN 和 EASO 共识声明。
Clin Nutr. 2022 Apr;41(4):990-1000. doi: 10.1016/j.clnu.2021.11.014. Epub 2022 Feb 22.
5
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement.定义和诊断肌少症性肥胖的标准:ESPEN 和 EASO 共识声明。
Obes Facts. 2022;15(3):321-335. doi: 10.1159/000521241. Epub 2022 Feb 23.
6
Skeletal muscle mass and quality: evolution of modern measurement concepts in the context of sarcopenia.骨骼肌质量与质量:在肌肉减少症背景下现代测量概念的演变
Proc Nutr Soc. 2015 Nov;74(4):355-66. doi: 10.1017/S0029665115000129. Epub 2015 Apr 8.
7
Ovarian cancer ascites induces skeletal muscle wasting in vitro and reflects sarcopenia in patients.卵巢癌腹水在体外诱导骨骼肌减少,并反映在患者的肌肉减少症中。
J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):311-324. doi: 10.1002/jcsm.12885. Epub 2021 Dec 23.
8
Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review.基于系统评价的肌少症性肥胖定义和诊断标准的评价。
Clin Nutr. 2020 Aug;39(8):2368-2388. doi: 10.1016/j.clnu.2019.11.024. Epub 2019 Nov 27.
9
Bioelectrical impedance analysis for diagnosing sarcopenia and cachexia: what are we really estimating?用于诊断肌肉减少症和恶病质的生物电阻抗分析:我们真正在评估什么?
J Cachexia Sarcopenia Muscle. 2017 Apr;8(2):187-189. doi: 10.1002/jcsm.12159. Epub 2017 Jan 31.
10
Differentiating Sarcopenia and Cachexia Among Patients With Cancer.癌症患者的肌肉减少症和恶病质的鉴别。
Nutr Clin Pract. 2017 Feb;32(1):30-39. doi: 10.1177/0884533616680354. Epub 2016 Dec 15.

引用本文的文献

1
Effects of functional task training on physical performance in older adults: a systematic review and meta-analysis.功能任务训练对老年人身体机能的影响:一项系统综述与荟萃分析
Eur Geriatr Med. 2025 Sep 18. doi: 10.1007/s41999-025-01310-z.
2
Change in D3Cr muscle mass in oldest old men and its association with changes in grip strength and walking speed.高龄男性D3Cr肌肉质量的变化及其与握力和步行速度变化的关联。
PLoS One. 2025 Apr 1;20(4):e0320752. doi: 10.1371/journal.pone.0320752. eCollection 2025.
3
Health outcomes of sarcopenia: a consensus report by the outcome working group of the Global Leadership Initiative in Sarcopenia (GLIS).
肌肉减少症的健康结局:全球肌肉减少症领导力倡议组织(GLIS)结局工作组的共识报告
Aging Clin Exp Res. 2025 Mar 22;37(1):100. doi: 10.1007/s40520-025-02995-9.
4
Poor muscle quality: A hidden and detrimental health condition in obesity.肌肉质量差:肥胖中一种隐藏且有害的健康状况。
Rev Endocr Metab Disord. 2025 Jan 21. doi: 10.1007/s11154-025-09941-0.
5
Accurate prediction of three-dimensional humanoid avatars for anthropometric modeling.准确预测三维拟人化角色以进行人体测量建模。
Int J Obes (Lond). 2024 Dec;48(12):1741-1747. doi: 10.1038/s41366-024-01614-3. Epub 2024 Aug 24.
6
Accurate Prediction of Three-Dimensional Humanoid Avatars for Anthropometric Modeling.用于人体测量建模的三维类人化身的准确预测
Res Sq. 2024 Jul 13:rs.3.rs-4565498. doi: 10.21203/rs.3.rs-4565498/v1.
7
Measures of physical function clarify the prognostic blur of cancer survivorship.身体功能指标明确了癌症幸存者预后的模糊性。
J Natl Cancer Inst. 2024 Jul 1;116(7):999-1001. doi: 10.1093/jnci/djae076.
8
Muscle parameters in fragility fracture risk prediction in older adults: A scoping review.老年人脆性骨折风险预测中的肌肉参数:范围综述。
J Cachexia Sarcopenia Muscle. 2024 Apr;15(2):477-500. doi: 10.1002/jcsm.13418. Epub 2024 Jan 29.
9
Estimating Muscle Mass Using D3-Creatine Dilution: A Narrative Review of Clinical Implications and Comparison With Other Methods.使用 D3-肌酸稀释法估算肌肉量:临床意义的叙述性综述及与其他方法的比较。
J Gerontol A Biol Sci Med Sci. 2024 Apr 1;79(4). doi: 10.1093/gerona/glad280.